Does HMSA Cover ADHD Treatment in Hawaii? A 2026 Guide

Last updated: July 16, 2026

Key update for 2026: HMSA (Hawaii Medical Service Association), an independent licensee of the Blue Cross and Blue Shield Association, uses CVS Caremark as its pharmacy benefit manager for commercial and group plans. Generic stimulants are typically available at Tier 1–2, while brand-name ADHD medications such as Adderall XR and Vyvanse generally require step therapy prior authorization at Tier 3–4. Under Hawaii law (HRS § 329-38.5), Schedule II stimulants must be prescribed electronically — though non-stimulant ADHD medications are non-scheduled and are not subject to this requirement. Coverage details vary by group plan; verify your specific benefits before booking an appointment.

If you have HMSA health insurance and have been diagnosed with ADHD — or suspect you or your child may have it — understanding your pharmacy and mental health benefits is an important first step. This guide walks through how HMSA’s CVS Caremark formulary typically covers ADHD medications in Hawaii, what prior authorization requirements may apply, and how Hawaii state law affects your prescription.

See if Klarity Health may be able to help with your ADHD treatment — check your options here.

About HMSA in Hawaii

HMSA (Hawaii Medical Service Association) is Hawaii’s largest health insurer and an independent licensee of the Blue Cross and Blue Shield Association. HMSA serves both commercial/employer-sponsored members and Medicare Advantage members through its Akamai Advantage plans. For commercial pharmacy benefits, HMSA contracts with CVS Caremark as its pharmacy benefit manager (PBM).

HMSA offers several plan types for employer-sponsored coverage in Hawaii, including PPO plans, HMO plans, and high-deductible health plans (HDHPs). Formulary tiers and prior authorization requirements may vary depending on your specific group contract. Always verify your individual plan benefits using your HMSA member portal or by calling 1-800-776-4672.

HMSA ADHD Medication Coverage: CVS Caremark Formulary Overview

The table below reflects typical CVS Caremark formulary placement for common ADHD medications under HMSA commercial plans. Actual tier placement and PA requirements vary by group plan year and contract.

Formulary tier placement is illustrative based on CVS Caremark commercial formulary standards. Your specific HMSA group plan may differ. Always verify coverage at hmsa.com or by calling CVS Caremark at 1-866-488-4708.

Hawaii EPCS Law and ADHD Prescriptions (HRS § 329-38.5)

Hawaii requires electronic prescribing for controlled substances under Haw. Rev. Stat. § 329-38.5. This statute covers Schedule II controlled substances only. Here is how this applies to ADHD medications:

• Stimulant medications (Schedule II): Amphetamine salts (Adderall, generic), methylphenidate (Ritalin, generic), lisdexamfetamine (Vyvanse, generic), and related compounds are Schedule II controlled substances. Under HRS § 329-38.5, prescribers in Hawaii must use electronic prescribing for these medications. Klarity Health providers are compliant with this requirement.
• Non-stimulant medications (non-scheduled): Atomoxetine (Strattera/generic), guanfacine ER (Intuniv/generic), clonidine ER (Kapvay/generic), and viloxazine (Qelbree) are not controlled substances and are therefore not subject to Hawaii’s EPCS mandate. Prescribers may use electronic or other compliant prescribing methods for these medications.

This is an important distinction from states such as West Virginia, which requires electronic prescribing for all controlled substances across multiple schedules. In Hawaii, Schedule IV and Schedule V controlled substances are not covered by this mandate — only Schedule II medications such as stimulants fall under HRS § 329-38.5.

Prior Authorization for ADHD Medications Under HMSA

Prior authorization (PA) may be required for certain ADHD medications under your HMSA plan. CVS Caremark typically manages this process on HMSA’s behalf. Common PA criteria may include:

• Confirmed ADHD diagnosis by a licensed clinician (DSM-5 diagnostic criteria)
• Documentation of medical necessity
• Step therapy requirements for brand stimulants: in many cases, your plan may require a trial of a lower-tier generic stimulant before approving a brand-name medication
• For adult ADHD: documentation of symptom onset, duration, and functional impairment may be requested
• Quantity limits may apply, particularly for certain extended-release formulations

To submit a PA request for an HMSA pharmacy benefit, providers typically contact CVS Caremark at 1-866-488-4708 or use the HMSA provider portal at prc.hmsa.com. Standard PA turnaround times are typically 2–3 business days; urgent/expedited requests may be processed within 24–72 hours depending on clinical urgency documentation.

If a PA request is denied, HMSA members have the right to request a formal appeal. HMSA’s appeals process includes an internal appeal followed by an external independent review if needed under Hawaii law.

Mental Health Parity and ADHD Coverage Under HMSA

Hawaii’s mental health parity law, Haw. Rev. Stat. § 431M-1 et seq., requires that state-regulated health plans provide mental health and substance use disorder (MH/SUD) benefits on terms no more restrictive than medical/surgical benefits. ADHD is classified as a mental health condition and is covered under parity protections for state-regulated commercial plans.

Under parity requirements, HMSA may not apply more restrictive prior authorization criteria, visit limits, or cost-sharing to ADHD treatment (evaluation, medication management, behavioral therapy) than it applies to comparable medical or surgical services.

Important note: Many large Hawaii employers operate self-funded health plans, which are governed by federal ERISA law rather than Hawaii state insurance statutes. Self-funded plans are still subject to federal MHPAEA parity requirements, but they are not subject to Hawaii’s § 431M-1 state parity law directly. If you are unsure whether your HMSA plan is fully insured or self-funded, review your Summary Plan Description or contact HMSA at 1-800-776-4672.

Hawaii Prepaid Health Care Act and Employer Coverage

Hawaii’s Prepaid Health Care Act (HRS § 393) requires most Hawaii employers to provide health insurance coverage to employees working at least 20 hours per week. This is a unique feature of Hawaii’s insurance landscape not found in most other states. As a result, employer-sponsored HMSA coverage is prevalent across Hawaii’s workforce.

The Prepaid Health Care Act does not mandate specific ADHD medication coverage or override HMSA’s formulary decisions — but it does ensure that most Hawaii workers have access to employer-sponsored health plans, making HMSA one of the most widely held commercial insurers in the state. For Prepaid Health Care Act questions, contact the Hawaii Department of Labor and Industrial Relations (DLIR) at 1-808-586-8777.

What ADHD Services May HMSA Cover?

HMSA commercial plans may typically provide coverage for the following ADHD-related services (subject to your plan’s specific terms):

• ADHD evaluation and diagnostic assessment: Covered visits with licensed psychiatrists, psychologists, or primary care providers who evaluate for ADHD
• Medication management visits: Follow-up appointments with prescribers for ongoing ADHD medication monitoring
• Behavioral therapy: Cognitive behavioral therapy (CBT) and other evidence-based therapies for ADHD symptom management
• Telehealth visits: Many HMSA plans now cover telehealth for mental health services, including ADHD evaluation and medication management, at parity with in-person visits
• ADHD medications: Covered through CVS Caremark pharmacy benefit, subject to formulary tier and PA requirements outlined above

How to Verify Your HMSA ADHD Benefits

1. Log in to your HMSA member portal at hmsa.com to review your specific plan’s formulary, cost-sharing, and benefits summary
2. Use the CVS Caremark formulary search tool (accessible via prc.hmsa.com) to check the current tier placement for your ADHD medication
3. Call HMSA member services at 1-800-776-4672 to ask about your specific mental health and pharmacy benefits for ADHD treatment
4. Ask your provider to run a benefits verification before your appointment to confirm coverage and PA requirements
5. Review your Summary Plan Description (SPD) for details on mental health benefits, prior authorization, and appeals rights

Getting ADHD Treatment Through Klarity Health

Klarity Health connects patients with over 2,000 licensed providers across the United States, including clinicians who may treat ADHD via telehealth. Klarity providers use electronic prescribing in compliance with Hawaii’s HRS § 329-38.5 EPCS requirement for Schedule II stimulants, and can work within your HMSA plan’s PA process when prior authorization is required.

Check whether Klarity Health may be able to connect you with an ADHD provider — see your options here.

Key Contacts

• HMSA Member Services: 1-800-776-4672 | hmsa.com
• CVS Caremark (HMSA PBM) — Provider PA Line: 1-866-488-4708
• CVS Caremark — Member Line: 1-800-552-8159
• HMSA Provider Resource Center: prc.hmsa.com
• Hawaii Insurance Division (Insurance Commissioner): 1-808-586-2790 | insurance.hawaii.gov
• Hawaii DLIR (Prepaid Health Care Act): 1-808-586-8777
• SAMHSA National Helpline: 1-800-662-4357
• 988 Suicide and Crisis Lifeline: Call or text 988

Frequently Asked Questions

Does HMSA cover Adderall?

Generic amphetamine salts (the generic form of Adderall) are typically covered at Tier 1–2 under HMSA’s CVS Caremark formulary with lower cost-sharing and may not require PA. Brand-name Adderall XR is typically placed at Tier 3–4 and in many cases requires step therapy prior authorization demonstrating a medical reason for the brand over generic. Coverage may vary by your specific group plan.

Does HMSA cover Vyvanse?

Brand-name Vyvanse (lisdexamfetamine) is typically placed at Tier 3–4 under CVS Caremark commercial formularies and may require prior authorization with step therapy documentation. Generic lisdexamfetamine (now available) is typically placed at Tier 2–3. Verify current tier placement with HMSA or CVS Caremark, as formularies are updated periodically.

Does HMSA cover non-stimulant ADHD medications?

Non-stimulant ADHD medications such as atomoxetine (generic Strattera), guanfacine ER (generic Intuniv), and clonidine ER (generic Kapvay) are typically covered at Tier 1–3 depending on the specific medication and formulation. These medications are non-scheduled and are not subject to Hawaii’s EPCS requirement. Viloxazine (Qelbree) is typically placed at Tier 2–3 and may require PA.

Do ADHD stimulants require an electronic prescription in Hawaii?

Yes. Under Haw. Rev. Stat. § 329-38.5, Hawaii requires electronic prescribing for Schedule II controlled substances, which includes all stimulant ADHD medications such as amphetamine salts and methylphenidate. Non-stimulant ADHD medications are not controlled substances and are not subject to this EPCS requirement in Hawaii.

What if my HMSA prior authorization for an ADHD medication is denied?

If your PA is denied, you have the right to appeal. HMSA’s internal appeals process typically involves submitting additional clinical documentation within the timeframe specified in your denial notice. If the internal appeal is also denied, you may request an external independent review. Contact HMSA at 1-800-776-4672 or the Hawaii Insurance Division at 1-808-586-2790 for guidance on your appeal rights.

Does the Hawaii Prepaid Health Care Act guarantee ADHD coverage?

The Prepaid Health Care Act (HRS § 393) requires most Hawaii employers to offer health coverage to employees working at least 20 hours per week, but it does not mandate coverage of specific ADHD medications or override HMSA’s formulary structure. Parity protections under Haw. Rev. Stat. § 431M-1 help ensure mental health benefits (including ADHD) are covered on comparable terms to medical/surgical benefits in state-regulated plans.

Disclaimer: This article is for informational purposes only and does not constitute insurance or legal advice. ADHD medication coverage under HMSA plans varies by group plan, formulary year, and individual circumstances. Always verify your specific benefits by contacting HMSA at 1-800-776-4672, reviewing your plan documents, or speaking with your provider before making treatment decisions. Coverage for specific medications is subject to change.